drugset / Trial / NCT05273671
Nalbuphine Versus Dexmedetomidine for Prevention of Emergence Agitation in Pediatrics
RandomizedParallel-groupTriple-blindPrevention
Summary
the investigators hypothesized that Nalbuphine may be alternative pharmacological agent for prevention of emergence agitation in pediatrics who will be scheduled for elective lower abdominal surgical procedures (inguinal hernia repair and hypospadias) during sevoflurane anesthesia
Timeline
- Start
- 2022-03-01
- Primary completion
- 2022-06-01
- Completion
- 2022-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.5 ug/kg | Intravenous |
| Subject | Nalbuphine | Small molecule | 0.1 mg/kg | Intravenous |
Indications
No indication recorded.